BGLC
Bionexus Gene Lab
$0.98
−$0.08 (−7.81%)Oct 29, 2026
Key metrics
The numbers that frame BGLC today
- Market cap
- $2.87M
- Gross margin
- 13.1%
- EV / Sales
- 0.6
- ROIC
- -38.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.98
- 52wk High
- $5.67
Growth
Revenue and earnings trend for BGLC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BGLC
Is Bionexus Gene Lab a good buy?
No. Bionexus Gene Lab has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Bionexus Gene Lab is selling at a very high price.
What is the market capitalization of BGLC?
Bionexus Gene Lab's market capitalization is $2.87M.
What is the 52-week high for BGLC stock?
The 52-week high for Bionexus Gene Lab is $5.67. The current close of $0.98 is 82.7% below that high.
What is the 52-week low for BGLC stock?
The 52-week low for Bionexus Gene Lab is $0.98. The current close of $0.98 is 0% above that low.
Does BGLC stock pay dividends?
Bionexus Gene Lab does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BGLC?
Bionexus Gene Lab's Debt / Equity ratio is 0.04.